Get the Stockscreener App
56.41
13.89%
6.88
After Hours:
56.22
-0.19
-0.34%
Tempus Ai Inc stock is traded at $56.41, with a volume of 12.38M.
It is up +13.89% in the last 24 hours and up +12.87% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$49.53
Open:
$50.35
24h Volume:
12.38M
Relative Volume:
2.26
Market Cap:
$10.12B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-40.09
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
+18.76%
1M Performance:
+12.87%
6M Performance:
-38.62%
1Y Performance:
+31.40%
1-Day Range:
$50.35
$56.50
1-Week Range:
$42.41
$56.50
52-Week Range:
$39.01
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
56.41 | 8.89B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
167.30 | 25.98B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
46.01 | 8.89B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
83.67 | 6.87B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.68 | 4.30B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
TEM Stock Jumps As ARK, Medtronic, Gilead Fuel AI Healthcare Story - timothysykes.com
Tempus AI (NASDAQ:TEM) Shares Up 10%What's Next? - MarketBeat
Tempus AI Target of Unusually Large Options Trading (NASDAQ:TEM) - MarketBeat
Tempus AI Stock Jumps 10% After Predicta Collaboration Expansion - Benzinga
Promising Artificial Intelligence Stocks Worth WatchingApril 15th - MarketBeat
Tempus AI Stock Jumps As ARK, Medtronic, Gilead Fuel Bull Case - timothysykes.com
TEM Stock: Tempus AI Aims for 25% Growth - CMC Markets
Tempus AI, Inc. And Predicta Biosciences Announce Collaboration To Expand Life Sciences Access To Ultrasensitive Whole-Genome Sequencing Assay For Hematologic Malignancies And MRD Monitoring - marketscreener.com
Tempus AI partners with Predicta on genomic sequencing assay - Investing.com
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring - Yahoo Finance
Tempus Presents 31 Abstracts at AACR Annual Meeting 2026 - National Today
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026 - BioSpace
Tempus AI jumps as investors focus on new “Active Follow-Up” workflow and Needham conference visibility - Quiver Quantitative
Tempus Announces 31 Abstracts for AACR 2026 - National Today
Tempus AI Stock Jumps As Data Presentations Fuel Fresh AI Oncology Buzz - Benzinga
Tempus AI (TEM) Announces Acceptance of 31 Abstracts for AACR An - GuruFocus
Promising Artificial Intelligence Stocks To Watch NowApril 14th - MarketBeat
Why Tempus AI Stock Is Quietly Climbing Higher - TipRanks
Gilead (GILD), Tempus AI (TEM) expand multi-year oncology R&D collaboration - MSN
Cancer meeting picks 31 Tempus studies, including an oral session - Stock Titan
tempus AI Inc Class A call volume above normal and directionally bullish - TipRanks
Tempus AI, Inc. Launches Automated Active Follow-Up Service - marketscreener.com
Mizuho Securities Initiates Tempus AI(TEM.US) With Buy Rating, Announces Target Price $100 - Moomoo
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care - 01net
Tempus AI (NASDAQ:TEM) Upgraded at TD Cowen - MarketBeat
Jefferies Financial Group Begins Coverage on Tempus AI (NASDAQ:TEM) - MarketBeat
TD Cowen Upgrades Tempus AI(TEM.US) to Buy Rating, Cuts Target Price to $65 - Moomoo
TD Cowen upgrades Tempus AI stock rating on stronger fundamentals - Investing.com
Tempus AI, Inc. $TEM Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Reiterating Buy: Tempus’s Underappreciated AI Data Advantage and Genomics Upside After a 50% Share Price Reset - TipRanks
Jefferies initiates Tempus AI stock with underperform rating By Investing.com - Investing.com Australia
Jefferies initiates Tempus AI stock with underperform rating - Investing.com
Tempus AI, Inc. $TEM Shares Sold by Baillie Gifford & Co. - MarketBeat
Jefferies initiates coverage of Tempus AI (TEM) with underperform recommendation - MSN
Tempus AI shares gain after expanded partnership with Gilead - MSN
Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration - Insider Monkey
Artificial Intelligence Stocks To Keep An Eye OnApril 12th - MarketBeat
Diversify Advisory Services LLC Has $2.86 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Does Tempus AI’s (TEM) Deeper Gilead Tie Mark a Shift in Its Platform Strategy? - simplywall.st
Artificial Intelligence Stocks To Watch NowApril 11th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
AI in Precision Medicine Market is expected to Hit US$ 16.95 - openPR.com
Tempus AI Sets $300 Million Volume Record as Gilead Deal Meets Selling Pressure - Bitget
HC Wainwright raises Tempus AI (TEM) price target to $95 - MSN
Tempus AI stock jumps, ALERT trial results boost EHR automation buzz - MSN
Best Artificial Intelligence Stocks Worth WatchingApril 10th - MarketBeat
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline - Sahm
Tempus AI stock rises on Gilead collaboration deal By Investing.com - Investing.com South Africa
Tempus AI stock rises on Gilead collaboration deal - Investing.com
Why Is Tempus AI Stock Gaining Friday?Tempus AI (NASDAQ:TEM) - Benzinga
Amazon, Snowflake, Tempus AI, Arrive AI and Eos Energy: Why these 5 stocks are on investors' radars today - MSN
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
2.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):